| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
CLINICAL STUDY |
1 Division of Endocrinology, Institute of Medicine, University of Bergen, and 2 Department of Medicine, Haukeland University Hospital, 5021 Bergen, Norway
(Correspondence should be addressed to K Løvås; Email: kristian.lovas{at}med.uib.no)
Objective: The conventional replacement therapy in Addison’s disease (AD) does not restore the normal diurnal cortisol rhythm. We explored the feasibility and safety of continuous s.c. hydrocortisone infusion (CSHI) as a novel mode of glucocorticoid replacement therapy.
Design and methods: Seven patients with AD were treated with CSHI in an open-labelled clinical study for up to three months. Adequacy of glucocorticoid replacement was assessed by 24 h blood and saliva sampling in one patient and by salivary cortisol day curves in six outpatients. Subjective health status was monitored by the Short Form-36 questionnaire.
Results: CSHI re-established the circadian variation and normal levels of cortisol in the patients, with minor day-to-day variation. Most of the patients could reduce their glucocorticoid dose considerably without adverse reactions. The treatment was well tolerated and positively evaluated by the patients.
Conclusions: CSHI is technically feasible and safe in patients with AD. A daily dose of ~10 mg/m2 body surface area/day restores the circadian variation and normal levels of salivary cortisol in most patients, which is close to the estimated daily requirement. We hypothesise that selected patients will benefit from restoration of the circadian cortisol rhythm.
This article has been cited by other articles:
|
|
 |
|
  K. Lovas, S. Curran, M. Oksnes, E. S. Husebye, F. A. Huppert, and V. K. K. Chatterjee Development of a Disease-Specific Quality of Life Questionnaire in Addison's Disease J. Clin. Endocrinol. Metab., February 1, 2010; 95(2): 545 - 551. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. M. Erichsen, K. Lovas, B. Skinningsrud, A. B. Wolff, D. E. Undlien, J. Svartberg, K. J. Fougner, T. J. Berg, J. Bollerslev, B. Mella, et al. Clinical, Immunological, and Genetic Features of Autoimmune Primary Adrenal Insufficiency: Observations from a Norwegian Registry J. Clin. Endocrinol. Metab., December 1, 2009; 94(12): 4882 - 4890. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Sherlock, R. C. Reulen, A. A. Alonso, J. Ayuk, R. N. Clayton, M. C. Sheppard, M. M. Hawkins, A. S. Bates, and P. M. Stewart ACTH Deficiency, Higher Doses of Hydrocortisone Replacement, and Radiotherapy Are Independent Predictors of Mortality in Patients with Acromegaly J. Clin. Endocrinol. Metab., November 1, 2009; 94(11): 4216 - 4223. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Filipsson and G. Johannsson GH replacement in adults: interactions with other pituitary hormone deficiencies and replacement therapies Eur. J. Endocrinol., November 1, 2009; 161(suppl_1): S85 - S95. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Raff Utility of Salivary Cortisol Measurements in Cushing's Syndrome and Adrenal Insufficiency J. Clin. Endocrinol. Metab., October 1, 2009; 94(10): 3647 - 3655. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Bryan, J. W. Honour, and P. C. Hindmarsh Management of Altered Hydrocortisone Pharmacokinetics in a Boy with Congenital Adrenal Hyperplasia Using a Continuous Subcutaneous Hydrocortisone Infusion J. Clin. Endocrinol. Metab., September 1, 2009; 94(9): 3477 - 3480. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Johannsson, R. Bergthorsdottir, A. G Nilsson, H. Lennernas, T. Hedner, and S. Skrtic Improving glucocorticoid replacement therapy using a novel modified-release hydrocortisone tablet: a pharmacokinetic study Eur. J. Endocrinol., July 1, 2009; 161(1): 119 - 130. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Lovas, C. G Gjesdal, M. Christensen, A. B Wolff, B. Almas, J. Svartberg, K. J Fougner, U. Syversen, J. Bollerslev, J. A Falch, et al. Glucocorticoid replacement therapy and pharmacogenetics in Addison's disease: effects on bone Eur. J. Endocrinol., June 1, 2009; 160(6): 993 - 1002. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Debono, R. J Ross, and J. Newell-Price Inadequacies of glucocorticoid replacement and improvements by physiological circadian therapy Eur. J. Endocrinol., May 1, 2009; 160(5): 719 - 729. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Wood Salivary steroid assays - research or routine? Ann Clin Biochem, May 1, 2009; 46(3): 183 - 196. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Arlt The Approach to the Adult with Newly Diagnosed Adrenal Insufficiency J. Clin. Endocrinol. Metab., April 1, 2009; 94(4): 1059 - 1067. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Bleicken, S. Hahner, M. Loeffler, M. Ventz, B. Allolio, and M. Quinkler Impaired subjective health status in chronic adrenal insufficiency: impact of different glucocorticoid replacement regimens Eur. J. Endocrinol., December 1, 2008; 159(6): 811 - 817. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
